Cargando…

Risk of QTc prolongation with Chloroquine/Hyroxychloroquine and Azithromycin treatment for COVID‐19: Quantification and precautions for a busy clinician

Detalles Bibliográficos
Autores principales:	Mansuri, Zeeshan, Adnan, Mahwish, Motiwala, Fatima, Zafar, Muhammad Khalid, Jolly, Taranjeet, Jain, Shailesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411207/ https://www.ncbi.nlm.nih.gov/pubmed/32782662 http://dx.doi.org/10.1002/joa3.12393

Ejemplares similares

Are Psychotropic Medications Effective in Chronic Pain Management in Children and Adolescents? A Meta-Analysis of Randomized Control Trials
por: Jolly, Taranjeet, et al.
Publicado: (2021)

QTc interval prolongation, COVID-19 and chloroquine
por: Wiwanitkit, V.
Publicado: (2020)

QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
por: Grewal, Sarah, et al.
Publicado: (2020)

Chloroquine-induced QTc prolongation in COVID-19 patients
por: van den Broek, M. P. H., et al.
Publicado: (2020)

QTc Prolongation in COVID-19 Patients Using Chloroquine
por: Becker, Matthijs L., et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2021)

The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
por: Sinkeler, F. S., et al.
Publicado: (2020)

Chloroquine: QTc prolongation following off-label use: case report
Publicado: (2022)

Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals
por: Brüggemann, R.J., et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine/tocilizumab: QTc prolongation and off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation and off label use: 3 case reports.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc prolongation during off-label treatment: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged QTc during off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc prolongation following off-label use: 2 case reports
Publicado: (2021)

Incidence of Sustained Ventricular Tachycardia in Patients with Prolonged QTc After the Administration of Azithromycin: A Retrospective Study
por: Sears, Steven P., et al.
Publicado: (2016)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021)

Chloroquine/lopinavir/ritonavir/umifenovir: QTc interval prolongation, drug interaction and off-label use: 2 case reports
Publicado: (2020)

Chloroquine/dalteparin sodium/hydroxycarbamide: Prolongation of the QTc interval secondary to off-label use and lack of efficacy: case report
Publicado: (2021)

Chloroquine: QTc interval prolongation leading to frequent extrasystoles and ventricular tachycardia following off label use: case report
Publicado: (2021)

Paroxetine‐induced QTc prolongation
por: Otsuka, Yuji
Publicado: (2017)

QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin
por: Hsia, Brian C, et al.
Publicado: (2020)

Problems with Bazett QTc correction in paediatric screening of prolonged QTc interval
por: Andršová, Irena, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Long QTc syndrome and hypoglycaemia: 3 case reports
Publicado: (2020)

Ketamine-induced QTc interval prolongation
por: Singh, Tejinder S. Swaran, et al.
Publicado: (2017)

Hydroxychloroquine: QTc prolongation: case report.
Publicado: (2020)

Evaluation of the potential for QTc prolongation with avelumab
por: Vugmeyster, Yulia, et al.
Publicado: (2019)

Ticagrelor-Induced Prolongation of the QTc Interval
por: Ray, Avik, et al.
Publicado: (2019)

An overview of QTc Prolongation with antipsychotics and antidepressants
por: Bhandari, Samrat Singh, et al.
Publicado: (2022)

The Effect of COVID-19 on QTc Prolongation
por: Alsallamin, Isaac, et al.
Publicado: (2022)

The corrected QT (QTc) prolongation in hyperthyroidism and the association of thyroid hormone with the QTc interval
por: Lee, Ye Seung, et al.
Publicado: (2015)

Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy
por: Chico, R Matthew, et al.
Publicado: (2008)

Azithromycin/chloroquine/tacrolimus: Cardiac disorders: case report
Publicado: (2021)

Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers
por: Chotsiri, Palang, et al.
Publicado: (2022)

Population pharmacokinetics of azithromycin and chloroquine in healthy adults and paediatric malaria subjects following oral administration of fixed-dose azithromycin and chloroquine combination tablets
por: Zhao, Qinying, et al.
Publicado: (2014)

A thorough QTc study demonstrates that olmesartan medoxomil does not prolong the QTc interval
por: Mendell, Jeanne, et al.
Publicado: (2015)

188 Evaluation of Baseline QTc Interval and Azithromycin Prescribing in an Academic Medical Center
por: Lee, Rachael, et al.
Publicado: (2014)

Associations of Prolonged QTc in Sickle Cell Disease
por: Indik, Julia H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_61dn2qi1a5bbpklqnhirhv5s2v